| Title : Platelet aggregation unchanged by lipoprotein-associated phospholipase A inhibition: results from an in vitro study and two randomized phase I trials - Shaddinger_2014_PLoS.One_9_e83094 |
| Author(s) : Shaddinger BC , Xu Y , Roger JH , Macphee CH , Handel M , Baidoo CA , Magee M , Lepore JJ , Sprecher DL |
| Ref : PLoS ONE , 9 :e83094 , 2014 |
| Abstract : |
| PubMedSearch : Shaddinger_2014_PLoS.One_9_e83094 |
| PubMedID: 24475026 |
| Title : Effect of treatment for 12 weeks with rilapladib, a lipoprotein-associated phospholipase A2 inhibitor, on arterial inflammation as assessed with 18F-fluorodeoxyglucose-positron emission tomography imaging - |
| Author(s) : Tawakol A , Singh P , Rudd JH , Soffer J , Cai G , Vucic E , Brannan SP , Tarka EA , Shaddinger BC , Sarov-Blat L , Matthews P , Subramanian S , Farkouh M , Fayad ZA |
| Ref : J Am Coll Cardiol , 63 :86 , 2014 |
| PubMedID: 23973698 |